吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Oct 29 2026 UPDATED 9:12 AM

Full Issue

HHS Permits Access To 6 Peptides Not Yet Approved By The FDA

The Department of Health and Human Services won't pursue legal action against compounding pharmacies that offer the peptides while the administration determines what rules to put in place to ensure the safety of the products. Plus, the healthcare concerns on the minds of candidates and voters heading into the midterm elections.

The Department of Health and Human Services is giving compounding pharmacies a temporary green light to make six peptides while the agency continues to work on a formal rule change. In a notice filed Wednesday, the agency said it would exercise 鈥渆nforcement discretion,鈥� meaning it will not take legal action against compounding pharmacies that make the six unapproved peptides. In practice, that means these pharmacies can start offering them now, even though the peptides aren鈥檛 yet on the Food and Drug Administration鈥檚 list of ingredients compounding pharmacies are allowed to make. (Lovelace Jr., 10/28)

Last November, the Department of Health and Human Services announced the elimination of 鈥渂lack box鈥� warnings on hormone replacement therapies, aiming to reverse nearly two decades of stigma surrounding a key treatment for menopause symptoms.聽Among the officials at a press conference about the decision was Alicia Jackson, director of a federal health agency that invests taxpayer money in medical technology and research. As Jackson stood behind a lectern adorned with the HHS logo, she praised the new policy, calling it a victory for women and science. (Johnson and Roberts, 10/29)

Amy Gleason, a little-known health tech entrepreneur, was catapulted into the public eye in February 2025 when she was revealed as the acting administrator of the controversial Department of Government Efficiency. Less than three months later, her husband got a job at an under-the-radar division of the US Department of Health and Human Services that had just been ravaged by DOGE-driven layoffs, according to people familiar with the matter. (Cohrs Zhang, 10/28)

Ever since the Treasury Department proposed to limit U.S. investment in the Chinese biotech industry last week, players across the U.S. are arguing over the significance of the restrictions. (Wilkerson and Garde, 10/29)

On the Nov. 3 midterm elections 鈥�

Abdul El-Sayed doesn鈥檛 make headlines as the Senate candidate who wrote a book on applying systems science to public health, or who worked to rebuild Detroit鈥檚 health system, or who researched the ways social circumstances can impact maternal mortality.聽(Oza, 10/28)

Voters across the country are furious over the high cost of health care, with resentment rippling across workers who get health coverage through their jobs. (Herman, 10/29)

吃瓜不打烊: The Campaign To Defend Trans Healthcare In Missouri Is Slow Going, On Purpose

Rene茅 Luckfield tries not to knock like a cop. In fact, the 29-year-old spends a lot of time thinking about how to make strangers comfortable when she shows up at their door to talk about transgender healthcare. A syncopated 鈥渢ap 鈥� tap-tap-tap鈥� sounds friendly even when she knocks loudly. In each encounter, she masks her own unease. 鈥淗onestly, it鈥檚 not something that I鈥檓 entirely comfortable with,鈥� Luckfield, a transgender woman, said while walking door to door in this affluent St. Louis suburb. 鈥淎nd it鈥檚 not fair that we have to do this work.鈥� (Sable-Smith, 10/29)

吃瓜不打烊: Data Center Health Worries Animate Midterm Campaigns

Doug Herrera still lives in the house his father built, though his dad died some time ago from cancer. Herrera wonders if that illness could have been linked to pollutants from nearby uranium mining. Now, he worries that a possible new neighbor 鈥� a proposed $10 billion mega data center 鈥� could imperil his health. 鈥淚鈥檓 a patriot, but I鈥檓 highly against the data center,鈥� Herrera, 64, said from his front porch near a yard sign that reads 鈥淣o Data Centers.鈥� 鈥淭here is light pollution, sound pollution. The temperature is going to rise,鈥� he said. (Armour and Seitz, 10/29)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, October 29
  • Wednesday, October 28
  • Tuesday, October 27
  • Monday, October 26
  • Friday, October 23
  • Thursday, October 22
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF